Related Experiment Video
Updated: May 11, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Management of recurrent hepatitis C in orthotopic liver transplant recipients
1Department of Infectious Diseases, Georgetown University Hospital, Washington, DC 20007, USA. Geeta.S.Karnik@gunet.georgetown.edu
Abstract:
End-stage liver disease and hepatocellular carcinoma from chronic hepatitis C are the most common indications for orthotopic liver transplantation and the incidence of both are projected to increase over the next decade. Recurrent hepatitis C virus infection of the allograft is associated with an accelerated progression to cirrhosis, graft loss, and death. This article presents an overview of the natural history of hepatitis C virus recurrence in liver transplant recipients and guidance on optimal management strategies.
Related Concept Videos
Hepatitis
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Viral Hepatitis I: Introduction
